157 results on '"Geisbert, Thomas W."'
Search Results
2. Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus
3. Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection
4. Nonhuman Primate Models for Nipah and Hendra Virus Countermeasure Evaluation
5. Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus Infection
6. Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates
7. A Glass-Half-Full Perspective on Negative Data in Ebolavirus Vaccine Studies
8. Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus
9. Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates
10. Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease
11. High-Avidity Anti-Filovirus IgG Elicited Using Protein Subunit Vaccines Does Not Correlate with Protection
12. Revisiting the minimum incubation period of Zaire ebolavirus
13. Single dose rVSVΔG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge
14. Combination therapy protects macaques against advanced Marburg virus disease
15. A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
16. Animal Models for Henipavirus Research
17. Modelling Marburg Virus Disease in Syrian Golden Hamsters: Contrasted Virulence between Angola and Ci67 strains
18. Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting
19. A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus
20. Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection
21. Limited benefit of post-exposure prophylaxis with VSV-EBOV in Ebola virus-infected rhesus macaques
22. Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody
23. Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona
24. A highly attenuated pan-filovirus VesiculoVax vaccine rapidly protects nonhuman primates against Marburg virus and three species of Ebolavirus
25. Pathogenesis of Aerosolized Ebola Virus Variant Makona in Nonhuman Primates
26. Limited Benefit of Postexposure Prophylaxis With VSV-EBOV in Ebola Virus–Infected Rhesus Macaques.
27. The Mucin-Like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets.
28. A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
29. A Recombinant Vesicular Stomatitis Virus–Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection.
30. Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats
31. Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection
32. A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
33. The therapeutic monoclonal antibody bamlanivimab does not enhance SARS‑CoV-2 infection by FcR-mediated mechanisms
34. An introduction to the Marburg virus vaccine consortium, MARVAC
35. Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report
36. Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials
37. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever
38. A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses.
39. Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques
40. Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
41. A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
42. Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
43. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
44. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
45. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses
46. Natural history of nonhuman primates after conjunctival exposure to Ebola virus
47. Rapid and Durable Protection Against Marburg Virus with a Single-Shot ChAd3-MARV GP Vaccine
48. Current state of Ebola virus vaccines: A snapshot
49. Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle
50. Pan-ebolavirus protective therapy by two multifunctional human antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.